Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: A pilot study

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 6, 2011, Pages 660-665

  Udompataikul, M ^a   Srisatwaja, W ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

atopic dermatitis; childhood; hydrocortisone; licochalcone A

Indexed keywords

CERAMIDE; HYDROCORTISONE; LANOLIN ALCOHOL; LICOCHALCONE A; LINOLEIC ACID;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRY SKIN; EDEMA; ERYTHEMA; FEMALE; HUMAN; LICHENOID ERUPTION; LOTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SCHOOL CHILD; SCORING OF ATOPIC DERMATITIS INDEX; SCORING SYSTEM; SKIN EXCORIATION; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; CHALCONES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EMOLLIENTS; FEMALE; HUMANS; HYDROCORTISONE; INFANT; KAPLAN-MEIER ESTIMATE; MALE; PATIENT SATISFACTION; PILOT PROJECTS; RECURRENCE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 79955928097     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03845.x     Document Type: Article

References (22)

1. Larsen FS, Hanifin JM,. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 1-24. (Pubitemid 34137417)
2. Wisuthsarewong W, Viravan S,. Diagnostic criteria for atopic dermatitis in Thai children. J Med Assoc Thai 2004; 87: 1496. PubMed 1500. [WWW document]. URL (last accessed: 28 August 2009).
3. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA,. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651. PubMed 7. [WWW document]. URL (last accessed: 2 September 2009).
4. Elias PM, Steinhoff M,. 'Outside-to-inside' (and now back to 'Outside') Pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-1070. (Pubitemid 351543225)
5. Ellis C, Luger T, Abeck D, et al. International consensus conference on atopic dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148 (Suppl. 63): 3-10.
6. Buys LM,. Treatment options for atopic dermatitis. Am Fam Phys 2007; 75: 523-528.
7. Williams HC,. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352: 2314. PubMed 24. [WWW document]. URL (last accessed: 7 September 2009).
8. Kolbe L, Immeyer J, Batzer J, et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 2006; 298: 23-30. (Pubitemid 43725209)
9. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1. PubMed 191. [WWW document]. URL (last accessed: 7 September 2009)
10. Hanifin JM, Rajka G,. Diagnosis features of atopic dermatitis. Acta Derm Venereol 1980 (Suppl. 92): 44-47.
11. Aalto-Korte K, Turpeinen M,. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 1995; 133: 259-263.
12. Weidinger S, Illig T, Baurcht H, et al. Loss-of-function variations within the fliaggrin gene predispose for atopic dermatitis with allergic sensitization. J Allergy Clin Immunol 2006; 118: 214-219. (Pubitemid 43949588)
13. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446. PubMed. [WWW document]. URL (last accessed: 11 October 2009).
14. Stefansson K, Brattsand M, Rootsterman D, et al. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J Invest Dermatol 2008; 128: 18-25. (Pubitemid 350249381)
15. Coderch L, Lopez O, Maza A, Parra JL,. Ceramides and skin function. Am J Clin Dermatol 2003; 4: 2107-2129.
16. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47: 198-208.
17. Barfod L, Kemp K, Hanse M, Kharazmi A,. Chalcones from Chinese liquorice inhibits proliferation of T cells and production of cytokines. Int Immunopharmacol 2002; 2: 545-555. (Pubitemid 34169749)
18. Weber T, Schoelerman A, Buerger A, Rizer R,. Tolerance and efficacy of a skin care regimen containing Licochalcone A with erythematous rosacea and facial redness. J Am Acad Dermatol 2005; 52: 95.
19. Charman C, William H,. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136: 763-769. (Pubitemid 30407434)
20. Hanifin JM, Hebert AA, Mays SR, et al. Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Clin Exp 1998; 59: 227-233. PubMed. [WWW document]. URL (last accessed: 15 November 2009). (Pubitemid 28206661)
21. Ainley-Walken PF, Patel L, David TJ,. Side to side comparison of topical treatment in atopic dermatitis. Arch Dis Child 1998; 79: 149-152. (Pubitemid 28384850)
22. Lucky AW, Leach AD, Laskerzewski P, Wenck H,. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324. (Pubitemid 27332923)